Global /India /Healthcare /Drug Manufacturers - General /CORONA

CORONA Remedies Ltd.

CORONA

• NSE: CORONA • Delayed

1,690.20INR 0.3%

17.65 USD

As of 5 June 2026, CORONA Remedies Ltd. has a market cap of $1.08B USD, ranking #10301 globally and #568 in India. It ranks #914 in the Healthcare sector, and #343 in the Drug Manufacturers - General industry.

Global Rank

10301

Country Rank

568

Sector Rank

914

Industry Rank

343

Key Stats

Market Cap

$1.08BUSD

103.37B INR

Enterprise Value

$1.08BUSD

103.46B INR

Revenue (TTM)

$140.34MUSD

13.44B INR

EBITDA (TTM)

$30.11MUSD

2.88B INR

Net Income (TTM)

$17.89MUSD

1.71B INR

EBITDA Margin

21%

Profit Margin

13%

PE Ratio

60.3

Forward PE

44.5

PS Ratio

7.7

PB Ratio

15.7

EV/EBITDA

35.4

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Niravkumar Mehta open_in_new

Employees

4,500

Founded

2004

Website

coronaremedies.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.3%	2.8%	6.9%	15%	17%	22%	17%	17%	17%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	CORONA ISIN: INE02ZQ01018 Shares Out.: Shares Outstanding: 61.16M¹ Shares Float: 6.877M² TV: TradingView: NSE: CORONA SA: Stock Analysis: NSE: CORONA YF: Yahoo Finance: CORONA.NS GF: Google Finance: NSE: CORONA BA: Barron's: CORONA MS: Morningstar: XNSE: CORONA	1,690.20 INR	TV: TradingView: NSE: CORONA SA: Stock Analysis: NSE: CORONA YF: Yahoo Finance: CORONA.NS GF: Google Finance: NSE: CORONA BA: Barron's: CORONA MS: Morningstar: XNSE: CORONA
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	CORONA ISIN: INE02ZQ01018 TV: TradingView: BSE: CORONA SA: Stock Analysis: BOM: CORONA YF: Yahoo Finance: CORONA.BO GF: Google Finance: BOM: CORONA BA: Barron's: CORONA MS: Morningstar: XBOM: CORONA	1,694.30 INR	TV: TradingView: BSE: CORONA SA: Stock Analysis: BOM: CORONA YF: Yahoo Finance: CORONA.BO GF: Google Finance: BOM: CORONA BA: Barron's: CORONA MS: Morningstar: XBOM: CORONA

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About CORONA Remedies Ltd.

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.57B 4.27T INR 4K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.12B 1.73T INR 2K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$14.95B 1.43T INR 1K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.57B 1.11T INR 971%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.73B 931.67B INR 801%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.57B 916.53B INR 787%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 70K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 51K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 33K%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 30K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 27K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 25K%	20.5	Switzerland

chevron_leftBack